Skip to main content
Clinical Trials/NCT05560802
NCT05560802RecruitingNot Applicable

Can the Use of a Next Generation Partograph Based on WHO's Latest Intrapartum Care Recommendations Improve Neonatal Outcomes? a Stepped-wedge Cluster Randomized Trial (PICRINO)

Linkoeping University24 sites in 1 country120,000 target enrollmentStarted: November 15, 2023Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
120,000
Locations
24
Primary Endpoint
The rate of intrapartum cesarean section

Study Overview

Brief Summary

The overall aim is to evaluate the impact of the use of two different guidelines for monitoring labor progress, the WHOs LCG versus standard care, on neonatal and maternal outcomes. The hypothesis is that the use of LCG will reduce adverse neonatal outcomes and decrease the number of intrapartum Cesarean sections compared with standard care.

Secondly, other perinatal interventions and complications will be compared between the LCG and standard care groups, as well as economic considerations. This will be investigated using a multicenter, stepped-wedge cluster randomized trial design.

In addition, the project will explore a series of quantitative and qualitative research questions to gain in-depth knowledge about experiences and perceptions about childbirth and the use of LCG. These research questions will be investigated using questionnaires, focus group and individual interviews with providers, partners and women that have gone through childbirth.

Detailed Description

Study Title

Can the use of a next generation partograph based on WHO's latest intrapartum care recommendations improve neonatal outcomes? A stepped-wedge cluster randomized trial (PICRINO).

Primary Objectives

To compare two different guidelines for monitoring labor progress, the the World Health Organization (WHO)'s Labour Care Guide (LCG) with standard care, and evaluate:

Adverse neonatal outcome, a composite outcome of perinatal mortality and neonatal morbidity. Neonatal morbidity will include five-minute Apgar score <7, hypoxic ischemic encephalopathy II-III, intracranial hemorrhage, neonatal seizures, meconium aspiration syndrome, and admission to a neonatal unit.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • All women in active labor

Exclusion Criteria

  • No exclusion criteria

Outcomes

Primary Outcomes

The rate of intrapartum cesarean section

Time Frame: 12 weeks up to 18 months

The rate of intrapartum cesarean section

Adverse neonatal outcome

Time Frame: 12 weeks up to 18 months

a composite outcome of perinatal mortality and neonatal morbidity. Neonatal morbidity will include five-minute Apgar score \<7, hypoxic ischemic encephalopathy II-III, intracranial hemorrhage, neonatal seizures, meconium aspiration syndrome, and admission to a neonatal unit.

Secondary Outcomes

  • Neonatal outcomes(12 weeks up to 18 months)
  • Obstetric outcomes(12 weeks up to 18 months)
  • Childbirth experience (women and partners)(12 weeks up to 18 months)
  • Economic evaluation(12 weeks up to 18 months)
  • Provider experience of LCG(12 weeks up to 18 months)

Investigators

Sponsor
Linkoeping University
Sponsor Class
Other Gov
Responsible Party
Principal Investigator
Principal Investigator

Marie Blomberg

Professor

Linkoeping University

Study Sites (24)

Loading locations...

Similar Trials